TD Issues Positive Forecast for Extendicare (TSE:EXE) Stock Price

Extendicare (TSE:EXE) had its price target boosted by research analysts at TD from C$32.00 to C$39.00 in a research note issued to investors on Monday,BayStreet.CA reports. The brokerage presently has a “buy” rating on the stock. TD’s target price points to a potential upside of 22.18% from the stock’s previous close.

EXE has been the subject of several other reports. Canadian Imperial Bank of Commerce increased their target price on Extendicare from C$22.00 to C$32.00 in a research report on Thursday, April 2nd. TD Securities upgraded Extendicare from a “hold” rating to a “buy” rating and increased their target price for the company from C$19.00 to C$32.00 in a research report on Monday, April 6th. BMO Capital Markets increased their target price on Extendicare from C$24.00 to C$30.00 in a research report on Monday, March 2nd. Desjardins set a C$34.50 target price on Extendicare and gave the company a “buy” rating in a research report on Wednesday, April 22nd. Finally, National Bank Financial increased their target price on Extendicare from C$24.50 to C$29.00 and gave the company an “outperform” rating in a research report on Thursday, February 5th. One research analyst has rated the stock with a Strong Buy rating and six have issued a Buy rating to the company’s stock. Based on data from MarketBeat, Extendicare currently has a consensus rating of “Buy” and an average price target of C$30.44.

Extendicare Price Performance

TSE:EXE traded down C$1.52 during trading hours on Monday, hitting C$31.92. The company’s stock had a trading volume of 300,655 shares, compared to its average volume of 317,838. The stock has a fifty day simple moving average of C$27.61 and a 200-day simple moving average of C$23.41. The company has a market capitalization of C$3.02 billion, a P/E ratio of 28.68 and a beta of 1.27. The company has a debt-to-equity ratio of 82.55, a current ratio of 1.44 and a quick ratio of 0.98. Extendicare has a twelve month low of C$12.12 and a twelve month high of C$35.62.

Extendicare (TSE:EXE) last released its quarterly earnings data on Thursday, May 7th. The company reported C$0.42 earnings per share for the quarter. The business had revenue of C$465.22 million for the quarter. Extendicare had a return on equity of 45.35% and a net margin of 6.99%. On average, analysts anticipate that Extendicare will post 0.6134729 EPS for the current fiscal year.

Extendicare Company Profile

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.